Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Precision BioSciences
DTIL
$205M
| $719K | ﹤0.01% |
7,779
+7,099
| +1,044% | +$965K |
|
2952
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $718K | ﹤0.01% |
21,000
-28,500
| -58% | -$964K |
|
|
CYBE
2953
DELISTED
Cyberoptics Corp
CYBE
| $718K | ﹤0.01% |
17,700
-12,453
| -41% | -$478K |
|
2954
Scully Royalty
SRL
$89.4M
| $717K | ﹤0.01% |
73,014
-8,320
| -10% | -$73.9K |
|
|
SBDS
2955
DELISTED
Solo Brands Inc
SBDS
| $717K | ﹤0.01% |
2,102
+872
| +71% | +$386K |
|
2956
Modine Manufacturing
MOD
$11.1B
| $715K | ﹤0.01% |
79,400
-15,009
| -16% | -$148K |
|
|
MTEM
2957
DELISTED
Molecular Templates, Inc.
MTEM
| $715K | ﹤0.01% |
13,810
-1,875
| -12% | -$82.8K |
|
2958
Emerson Radio
MSN
$7.91M
| $712K | ﹤0.01% |
927,088
-71,326
| -7% | -$54K |
|
2959
First Western Financial
MYFW
$310M
| $711K | ﹤0.01% |
22,752
+7,552
| +50% | +$245K |
|
2960
Q32 Bio
QTTB
$451M
| $711K | ﹤0.01% |
13,000
+4,889
| +60% | +$304K |
|
|
ALE
2961
DELISTED
Allete
ALE
| $710K | ﹤0.01% |
+10,600
| New | +$682K |
|
|
RNAM
2962
DELISTED
Avidity Biosciences
RNAM
| $709K | ﹤0.01% |
38,400
+26,800
| +231% | +$455K |
|
2963
iShares Europe ETF
IEV
$1.7B
| $708K | ﹤0.01% |
+14,100
| New | +$725K |
|
|
KSPN
2964
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $708K | ﹤0.01% |
97,553
-2,100
| -2% | -$16.9K |
|
2965
Stagwell
STGW
$2.23B
| $704K | ﹤0.01% |
97,200
-117,000
| -55% | -$878K |
|
|
FLZH
2966
Flash Sports & Media Holdings
FLZH
$71.1M
| $703K | ﹤0.01% |
2,619
-1,965
| -43% | -$490K |
|
2967
Solitario Resources
XPL
$75.7M
| $703K | ﹤0.01% |
833,018
-12,100
| -1% | -$7.55K |
|
2968
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $701K | ﹤0.01% |
14,300
-15,200
| -52% | -$759K |
|
2969
HBT Financial
HBT
$1.35B
| $700K | ﹤0.01% |
38,500
+5,010
| +15% | +$95.4K |
|
2970
Larimar Therapeutics
LRMR
$453M
| $700K | ﹤0.01% |
172,742
-20,032
| -10% | -$131K |
|
|
ALIM
2971
DELISTED
Alimera Sciences
ALIM
| $699K | ﹤0.01% |
124,793
-3,600
| -3% | -$17.5K |
|
2972
Invesco Dorsey Wright Momentum ETF
PDP
$1.54B
| $697K | ﹤0.01% |
+8,600
| New | +$698K |
|
2973
KLX Energy Services
KLXE
$35.3M
| $696K | ﹤0.01% |
+134,558
| New | +$820K |
|
|
BBT
2974
Beacon Financial Corp
BBT
$2.69B
| $695K | ﹤0.01% |
+24,000
| New | +$722K |
|
2975
Celcuity
CELC
$4.49B
| $695K | ﹤0.01% |
74,356
+43,800
| +143% | +$456K |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.